SMTL ID : 2vag.1

Crystal structure of di-phosphorylated human CLK1 in complex with a novel substituted indole inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.80 Å

Oligo State

monomer

Ligands

1 x V25: ethyl 3-[(E)-2-amino-1-cyanoethenyl]-6,7-dichloro-1-methyl-1H-indole-2-carboxylate(Non-covalent)

V25.1: 17 residues within 4Å: Chain A: L.22, G.23, E.24, G.25, F.27, V.30, A.44, K.46, V.80, F.96, E.97, L.99, E.147, N.148, L.150, V.179, D.180 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:V.30, A:V.80, A:F.96, A:E.147, A:L.150, A:V.179, A:V.179, A:V.179 Hydrogen bonds: A:E.147 Water bridges: A:N.148, A:D.180 Halogen bonds: A:L.99

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Fedorov, O. et al., Specific Clk Inhibitors from a Novel Chemotype for Regulation of Alternative Splicing. Chem.Biol (2011)

Release Date

2007-10-09

Peptides

DUAL SPECIFICITY PROTEIN KINASE CLK1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

DUAL SPECIFICITY PROTEIN KINASE CLK1

Related Entries With Identical Sequence